About Lophius Biosciences
Lophius Biosciences is a company based in Regensburg (Germany) founded in 2008.. Lophius Biosciences has raised $23.73 million across 9 funding rounds from investors including European Union, VRD and Bayern Kapital. The company has 28 employees as of December 31, 2019. Lophius Biosciences operates in a competitive market with competitors including HYCOR BioMedical, Exagen, PredictImmune, Kypha and Immudex, among others.
- Headquarter Regensburg, Germany
- Employees 28 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lophius Biosciences Gmbh
-
Annual Revenue
-
Net Profit
$-2.75 M (USD)-20as on Dec 31, 2019
-
EBITDA
-
Total Equity Funding
$23.73 M (USD)
in 9 rounds
-
Latest Funding Round
$3.43 M (USD), Series B
Sep 19, 2019
-
Investors
European Union
& 6 more
-
Employee Count
28
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lophius Biosciences
Lophius Biosciences has successfully raised a total of $23.73M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $3.43 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series B — $3.4M
-
First Round
First Round
(02 Oct 2008)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Series B - Lophius Biosciences | Valuation | VRD |
|
| Mar, 2017 | Amount | Series B - Lophius Biosciences | Valuation | VRD | |
| Jul, 2016 | Amount | Series A - Lophius Biosciences | Valuation | VRD |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lophius Biosciences
Lophius Biosciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, VRD and Bayern Kapital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment partnerships are provided by a family office for wealth growth.
|
Founded Year | Domain | Location | |
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lophius Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lophius Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lophius Biosciences Comparisons
Competitors of Lophius Biosciences
Lophius Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Exagen, PredictImmune, Kypha and Immudex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
|
|
| domain | founded_year | HQ Location |
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
|
|
| domain | founded_year | HQ Location |
Tools for diagnosing immune-mediated inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of immune monitoring reagents and services for research and clinical use
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lophius Biosciences
Frequently Asked Questions about Lophius Biosciences
When was Lophius Biosciences founded?
Lophius Biosciences was founded in 2008.
Where is Lophius Biosciences located?
Lophius Biosciences is headquartered in Regensburg, Germany. It is registered at Regensburg, Bavaria, Germany.
Is Lophius Biosciences a funded company?
Lophius Biosciences is a funded company, having raised a total of $23.73M across 9 funding rounds to date. The company's 1st funding round was a Series A of $4.67M, raised on Oct 02, 2008.
How many employees does Lophius Biosciences have?
As of Dec 31, 2019, the latest employee count at Lophius Biosciences is 28.
What does Lophius Biosciences do?
Develops T-cell-based diagnostics for infectious and immune diseases. It has two proprietary platforms, T-activation Technology which allows the detection of clinically relevant effector cells such as T helper, NK, NKT-like, and CTL cells,and Reverse T cell Technology (RTT) which detects pathogen-specific activated T-cells. The company has two diagnostic kits on the market based on their proprietary platform. T-TRACK CMV for the HLA-independent detection of CMV-specific cell-mediated immunity, and T-TRACK IMMUNOSCAN to check immune response due to natural, induced immunomodulation, In addition, Lophius also provides services and T-cell-based research tools for researchers and biopharma companies.
Who are the top competitors of Lophius Biosciences?
Lophius Biosciences's top competitors include Exagen, SmartHealth and HYCOR BioMedical.
Who are Lophius Biosciences's investors?
Lophius Biosciences has 7 investors. Key investors include European Union, VRD, Bayern Kapital, Wohnen in Chemnitz, and BIOTEC KW WOLF.